Cleared Traditional

K972538 - FLOW-EZE BLUNT CANNULA (1999BC)

K972538 is an FDA 510(k) clearance for FLOW-EZE BLUNT CANNULA (1999BC), manufactured by Acacia, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 372-day FDA review.

K972538 · Acacia, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1998
Decision
372d
Days
Class 2
Risk

K972538 is an FDA 510(k) clearance for the FLOW-EZE BLUNT CANNULA (1999BC). Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Acacia, Inc. (Ojai, US). The FDA issued a Cleared decision on July 15, 1998 after a review of 372 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Acacia, Inc. devices

FDA 510(k) Submission Details - K972538

510(k) Number K972538 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 1997
Decision Date July 15, 1998
Days to Decision 372 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
243d slower than avg
Panel avg: 129d · This submission: 372d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 402
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K972538.
VACUTAINER BRAND ECLIPSE BLOOD COLLECTION NEEDLE, MODELS# 368607 & 368608
K982541 · Becton Dickinson Vacutainer Systems · Oct 1998
BLUNT SYRINGE CANNULA
K971924 · B.Braun Medical, Inc. · Sep 1998
DISETRONIC PENFINE INJECTION PEN NEEDLE
K982399 · Disetronic Medical Systems · Aug 1998
VACUETTE MULTIPLE SAMPLE LUER ADAPTER
K981619 · Greiner Meditech, Inc. · Jul 1998
WORLDWIDE MEDICAL TECHNOLOGIES INTRACERVICAL BLOCK NEEDLE, MODEL TBD
K982097 · Worldwide Medical Technologies, LLC · Jun 1998
SHARPTRACK REUSABLE SHARPS CONTAINER
K981184 · Bfi- Medical Waste Systems · Jun 1998